Emi H. Caywood, MD
Hematology/OncologyPrimary Office
Other Offices
-
Nemours Children's Health, Philadelphia Nemours Children's Health, Philadelphia 833 Chestnut St. E. Suite 300 - Specialty Care Philadelphia, PA 19107 Appointment: (800) 416-4441
Get to Know Me
With a passion for science and my desire to always work with people, I decided to pursue becoming a doctor after college. Today, I’m incredibly fortunate to help treat children with a variety of cancers and blood disorders – including eye tumors.Why I Treat Children
I’m amazed by their resilience, honesty and innocence – and I want to help make their life the best it can possibly be The children I treat didn’t ask for the medical conditions they have, and they deserve the best that is in me.Education & Training
Fellowship
- Pediatric Hematology/Oncology - Johns Hopkins University, 2009
Residency
- Pediatrics - Georgetown University Hospital (MedStar Health), 2005
Medical/Dental School
- MD - University of Medicine and Dentistry of New Jersey, 2002
Board Certifications
- American Board of Pediatrics/Pediatric Hematology-Oncology
Awards & Recognition
- 2014 Delaware Today magazine, Top Doctors
- 2013 Hyundai Hope on Wheels Grant Scholar
- 2008 Fellow Award Finalist, American Society of Hematology
Insurance Accepted
- Aetna Better Health PA Kids HMO
- Aetna HMO
- Aetna PPO/POS/EPO
- Amerihealth Caritas DE - PENNSYLVANIA SPECIALISTS ONLY
- Amerihealth Caritas Delaware
- Carefirst MD Community Health Plan Mcaid
- Carefirst MD Community Health Plan Mcaid
- Cigna/Great West HMO EPO POS
- Cigna/Great West PPO
- Delaware First Health
- Delaware Medicaid/Diamond State
- Delaware Medicare
- Devon Health Services
- Fidelis Care NJ Medicaid HMO
- First Health/Affordable PPO
- Geisinger Health Plan Commercial
- Global Medical Managment DE/PA
- Health Partners Medicaid/Kidz Partner HMO
- Highmark Blue Cross Blue Shield Delaware Traditional
- Highmark Blue Cross Blue Shield Delware HMO PPO POS EPO
- Highmark Medicaid Health Options
- Highmark PA CHIP & Commercial
- Horizon Blue Cross and Blue Shield NJ HMO
- Horizon Blue Cross and Blue Shield of NJ PPO
- Independence Blue Cross/Amerihealth/Keystone HMO PPO
- Insurance Administrators of America
- INTEGRA Administrative Group (ClaimsBridge)
- Interlink Transplant
- Keystone First Medicaid HMO
- Lifetrac Transplant
- Maryland Medicaid
- Multiplan PPO
- New Jersey Medicaid
- Pennsylvania Medicaid
- Plan Vista/NPPN PPO
- Preferred Healthcare PPO
- Private Health Care Systems (PHCS)
- Qualcare HMO/POS/PPO
- Star Healthcare Network
- Three Rivers Provider Network
- Tricare/Humana Military Health Services
- United Healthcare of the Mid-Atlantic
- UPMC MCAID/CHIP PA DE
- US Family Health Plan
- Wellpoint Maryland Medcaid
Medical Interests
- Acute myeloid leukemia (AML)
-
Subburaj, D., Ng, B., Kariminia, A., Abdossamadi, S., Lauener, M., Nemecek, E. R., & Schultz, K. R. (2022). Metabolomic identification of alpha-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease. Blood, 139(2), 287-299. doi:10.1182/blood.2021013244
View Full Publication -
Getz, K. D., Szymczak, J. E., Li, Y., Madding, R., Huang, Y.-S. V., Aftandilian, C., & Aplenc, R. (2021). Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management after Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Network Open, 4(10). doi:10.1001/jamanetworkopen.2021.28385
View Full Publication -
Schultz, K. R., Kariminia, A., Ng, B., Abdossamadi, S., Lauener, M., Nemecek, E. R., & Cuvelier, G. D. E. (2020). Immune profile differences between chronic GVHD and late acute GVHD: Results of the ABLE/PBMTC 1202 studies. Blood, 135(15), 1287-1298. doi:10.1182/BLOOD.2019003186
View Full Publication -
Chan, A. Y., Leiding, J. W., Liu, X., Logan, B. R., Burroughs, L. M., Allenspach, E. J., & Torgerson, T. R. (2020). Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.00239
View Full Publication -
Dvorak, C. C., Haddad, E., Buckley, R. H., Cowan, M. J., Logan, B., Griffith, L. M., & Puck, J. M. (2019). The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). Journal of Allergy and Clinical Immunology, 143(1), 405-407. doi:10.1016/j.jaci.2018.08.027
View Full Publication -
Cuvelier, G. D. E., Nemecek, E. R., Wahlstrom, J. T., Kitko, C. L., Lewis, V. A., Schechter, T., & Schultz, K. R. (2019). Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria. Blood, 134(3), 304-316. doi:10.1182/blood.2019000216
View Full Publication -
Shields, C. L., Say, E. A. T., Pefkianaki, M., Regillo, C. D., Caywood, E. H., Jabbour, P. M., & Shields, J. A. (2017). RHEGMATOGENOUS RETINAL DETACHMENT after INTRAARTERIAL CHEMOTHERAPY for RETINOBLASTOMA: The 2016 Founders Award Lecture. Retina, 37(8), 1441-1450. doi:10.1097/IAE.0000000000001382
View Full Publication -
Shields, C. L., Alset, A. E., Say, E. A. T., Caywood, E., Jabbour, P., & Shields, J. A. (2016). Retinoblastoma control with primary intra-arterial chemotherapy: Outcomes before and during the intravitreal chemotherapy era. Journal of Pediatric Ophthalmology and Strabismus, 53(5), 275-284. doi:10.3928/01913913-20160719-04
View Full Publication -
Shields, C. L., Jorge, R., Say, E. A. T., Magrath, G., Alset, A., Caywood, E., & Shields, J. A. (2016). Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of retinoblastoma. Asia-Pacific Journal of Ophthalmology, 5(2), 97-103. doi:10.1097/APO.0000000000000172
View Full Publication -
Lewen, M., Gresh, R., Queenan, M., Paessler, M., Pillai, V., Hexner, E., & Wertheim, G. (2016). Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report. Biomarker Research, 4(1). doi:10.1186/s40364-016-0069-0
-
Caywood, E. H., & Kolb, E. A. (2015). Challenges in converting Acute Myeloid Leukemia (AML) genomics into AML clinical trials. Journal of Clinical Oncology, 33(36), 4238-4239. doi:10.1200/JCO.2015.63.9252
View Full Publication -
Hossain, M. J., Xie, L., & Caywood, E. H. (2015). Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: Evidence from four decades of US population data. Cancer Epidemiology, 39(5), 720-726. doi:10.1016/j.canep.2015.06.009
View Full Publication
- English